| Title | Author(s) | Year | View Count |
 | Screening of occult HBV infection in blood donors in Hong Kong using nucleic acid testing | Wong, DKH; Lai, CL; Fung, JYY; Lee, CK; Lin, CK; Hung, IFN; But, D; Hsu, A; Chan, P; Cheung, TK; Fung, FKC; Yuen, JCH; Young, JLP; Ngai, WS; Yuen, RMF | 2008 | 153 |
| One-year treatment of entecavir results in reduction in intrahepatic covalently closed circular DNA level | Wong, DKH; Yuen, RMF; Ngai, WS; Kwok, CL; Lai, CL | 2005 | 71 |
| Interim report on a phase I/IIa, double-blind, randomized, placebo-controlled trial of a novel antiviral agent, LB80380 in Chinese patients with chronic hepatitis B infection | Yuen, RMF; Kim, J; Wong, DKH; Ngai, WS; Yuen, JCH; Lai, CL | 2004 | 146 |
| Interim report on a phase I/IIa, double-blind, randomized, placebo-controlled trial of a novel antiviral agent, LB80380 in Chinese patients with chronic hepatitis B infection. | Yuen, RMF; Kim, J; Wong, DKH; Ngai, WS; Yuen, JCH; Lai, CL | 2004 | 131 |
| Phase I/II double-blind, randomized, placebo-controlled study of the novel anti-HBV agent LB80380/ANA380 in patients with chronic HBV infection. | Yuen, RMF; Kim, J; Averett, D; Wong, DKH; Kim, CR; Kerr, B; Ngai, WS; Yuen, JCH; Lai, CL | 2004 | 198 |
| A phase I/IIa, double-blind, randomized, placebo-controlled trial of a novel antiviral agent, LB80380 in patients with chronic hepatitis B infection | Yuen, RMF; Kim, J; Wong, DKH; Ngai, WS; Yuen, JCH; Lai, CL | 2003 | 152 |
|
